Moneycontrol
Get App
you are here:

IDBI Healthcare Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : IDBI Mutual Fund
  • NAV
    : ₹ 12.75 -0.39%
    (as on 01st June, 2020)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High
(Min ₹500 for SIP, ₹5000 for one time investment)

Fund has 94.26% investment in indian stocks of which 51.35% is in large cap stocks, 37.58% is in mid cap stocks, 5.33% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    S&P BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • S&P BSE Healthcare TRI : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 29th May, 2020)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 22-May-20 10007.80 0.08% - 6.47% 109/111
1 Month 29-Apr-20 10070.80 0.71% - 0.47% 65/110
3 Month 28-Feb-20 11829.90 18.30% - -10.55% 5/111
6 Month 29-Nov-19 12075.50 20.76% - -13.38% 4/108
YTD 01-Jan-20 12052.70 20.53% - -13.73% 6/109
1 Year 29-May-19 12994.90 29.95% 29.86% -12.32% 3/102
Since Inception 28-Feb-19 12800.00 28.00% 21.85% 5.70% 2/120

SIP Returns (NAV as on 29th May, 2020)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 29-May-19 12000 14826.47 23.55 % 46.3 %
 

Tax Treatment

Portfolio (Updated on 30th Apr,2020)

Portfolio Turnover Ratio : 59.00%  |   Category average turnover ratio is 150.22%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 94.26% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 94.26%
No of Stocks : 24 (Category Avg - 32.64) | Large Cap Investments : 51.35%| Mid Cap Investments : 37.58% | Small Cap Investments : 5.33% | Other : 0%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 44.1 12.48% -0.03% 12.57% (Jan 2020) 8.98% (Jun 2019) 95.00 k 0.00
Dr. Reddys Laboratories Ltd. Pharmaceuticals 39.4 11.13% -0.54% 11.67% (Mar 2020) 0% (May 2019) 10.00 k 0.00
Divis Laboratories Ltd. Pharmaceuticals 32.7 9.24% -1.17% 10.41% (Mar 2020) 5.65% (May 2019) 14.00 k 0.00
Cipla Ltd. Pharmaceuticals 23.6 6.67% 0.35% 7.64% (Dec 2019) 5.29% (May 2019) 40.00 k 0.00
Ipca Laboratories Ltd. Pharmaceuticals 19.4 5.49% -0.76% 6.88% (Feb 2020) 4.11% (Jun 2019) 12.00 k 0.00
Lupin Ltd. Pharmaceuticals 18.6 5.26% 0.36% 6.19% (Nov 2019) 4.8% (Feb 2020) 22.25 k 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 13.8 3.89% 0.49% 5.97% (May 2019) 3.4% (Jan 2020) 22.00 k 0.00
Sanofi India Ltd. Pharmaceuticals 13.2 3.74% -0.23% 5.59% (Dec 2019) 3.74% (Apr 2020) 1.70 k 0.00
Abbott India Ltd. Pharmaceuticals 12.9 3.66% -0.55% 4.21% (Mar 2020) 2.13% (Jul 2019) 729.00 0.00
Pfizer Ltd. Pharmaceuticals 12.3 3.47% -0.29% 4.05% (Dec 2019) 2.71% (Aug 2019) 2.50 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 5.03%
Net Receivables Net Receivables 0.71%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th May, 2020)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Mirae Asset Healthcare Fund - Growth NA 526.28 2.46 19.68 25.23 34.52 0.00
DSP Healthcare Fund - Regular Plan - Growth NA 371.98 3.71 10.77 21.44 31.49 0.00
Nippon India Pharma Fund - Growth NA 2850.69 3.91 19.86 23.04 29.47 15.10
UTI Healthcare - Growth NA 459.25 3.39 19.52 21.26 28.11 8.45
Tata India Pharma & Heathcare Fund - Growth NA 219.68 2.51 12.62 19.05 27.23 9.20
ICICI Prudential US Bluechip Equity Fund - Growth NA 587.22 3.64 8.95 3.54 26.98 16.39
SBI Healthcare Opportunities Fund - Regular Plan - Growth NA 1103.06 1.79 12.88 18.78 26.05 5.40
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth NA 1434.08 2.65 18.77 19.46 25.86 0.00
Nippon India US Equity Opportunities Fund - Growth NA 121.77 7.96 12.18 6.72 23.52 17.69
Nippon India Japan Equity Fund - Growth NA 33.99 7.76 6.46 -3.17 13.65 7.46

More Funds from IDBI Mutual Fund

Out of 23 mutual fund schemes offered by this AMC, 4 is/are ranked 4 * , 3 is/are ranked 3 * , 1 is/are ranked 2 * , 4 is/are ranked 1 * , and 11 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
IDBI Liquid Fund - Growth 1 1152.96 0.44 1.50 2.82 5.97 6.78
IDBI Equity Advantage Fund - Growth 4 464.80 -0.17 -13.11 -15.32 -9.94 -0.25
IDBI India Top 100 Equity Fund - Growth 4 325.15 -0.45 -11.11 -14.38 -10.15 -1.77
IDBI Diversified Equity Fund - Regular Plan - Growth 4 258.95 0.59 -12.49 -14.29 -11.11 -1.06
IDBI Hybrid Equity Fund- Growth 4 213.52 1.04 -5.83 -6.36 -7.74 -1.58
IDBI Nifty Index Fund - Growth 3 185.55 -0.36 -12.35 -18.74 -17.43 0.46
IDBI Midcap Fund - Growth 3 152.89 2.41 -16.17 -14.40 -15.85 -6.20
IDBI Focused 30 Equity Fund - Growth NA 144.31 0.23 -10.26 -13.54 -12.26 0.00
IDBI Ultra Short Term Fund - Growth 3 113.72 0.92 0.92 2.45 7.60 6.40
IDBI Small Cap Fund - Growth NA 97.02 0.00 -20.77 -19.53 -24.54 0.00

Forum

View More